Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion type Assertion NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_head.
- NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_provenance.
- NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion evidence source_evidence_literature NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_provenance.
- NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion SIO_000772 23660859 NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_provenance.
- NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion wasDerivedFrom befree-20150227 NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_provenance.
- NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion wasGeneratedBy ECO_0000203 NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_provenance.